Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Medplus Health Services Legal & Regulatory

MedPlus Health Services reported a 7-day drug license suspension for its subsidiary Optival Health Solutions. The action carries an estimated financial impact of Rs 0.12 Crore.

Key figures
Value₹0.12 Cr
Order fromAssistant Director Drugs Control Administration, Mangalore Circle
Execution period7 days
Source

BSE filing, NSE: MEDPLUS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Medplus Health Services Ltd: key numbers

Share price
₹610.60
Market cap
₹7,336 Cr
Revenue (annual)
₹6,892 Cr
Net profit (annual)
₹219.7 Cr
P/E (TTM)
34.8×Sector 51.1×
Promoter holding
40.19%+0.00% QoQ
FII holding
12.58%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Medplus Health Services Ltd

All →

Other legal & regulatory announcements

All →